SCHEMBL15410034

SCHEMBL15410034

O=C(Nc1c(F)c(F)c(C(F)(F)F)c(F)c1F)c1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ11 Q14654 1/20 0.47
RAB9A P51151 3/20 0.44
TP53 P04637 2/20 0.44
NPC1 O15118 2/20 0.44
MAPK1 P28482 1/20 0.44
OGG1 O15527 1/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 2/20 0.42
RXFP1 Q9HBX9 1/20 0.41
XBP1 P17861 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
ADCY1 Q08828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15410493 0.84 TSHR (0.42) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL15409614 0.84 RAB9A (0.52) KCNJ11RAB9ATP53NPC1MEN1
SCHEMBL15410033 0.84 NPC1 (0.54) KCNJ11RAB9ATP53NPC1MEN1
SCHEMBL15410726 0.83 TRPV1 (0.59) RAB9ATP53NPC1MEN1KMT2A
SCHEMBL15410723 0.82 KCNJ11 (0.52) KCNJ11RAB9ATP53NPC1MEN1
SCHEMBL15409617 0.81 TSHR (0.56) KCNJ11RAB9ATP53NPC1MAPK1
SCHEMBL15411234 0.81 MLYCD (0.55) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL15411337 0.80 NPC1 (0.53) RAB9ATP53NPC1MEN1KMT2A
SCHEMBL14716260 0.77 TSHR (0.56) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL19097365 0.76 HPGD (0.49) RAB9ANPC1KMT2AMAPTXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140018566-A1 PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES THE SCRIPPS RESEARCH INSTITUTE (US) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018566-A1 PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES AHR, DDT, AOC2 KCNJ11 1353/4885RAB9A 661/4885TP53 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.